AntimicrobialEmerging Evidence

Antimicrobial Peptides Overview

Also known as: AMPs, Host defense peptides, HDPs

Broad class of innate immune peptides with antimicrobial, immunomodulatory, and wound-healing properties representing next-generation anti-infectives.

Benefits

7

Conditions

6

Evidence

Extensive preclinical research, limited approved therapeutics, clinical trials ongoing+ studies

Source

Natural host defense peptides (human, animal, plant) or synthetic analogs

Overview

Broad class of innate immune peptides with antimicrobial, immunomodulatory, and wound-healing properties representing next-generation anti-infectives.

Mechanism of Action

Diverse mechanisms including membrane disruption (pore formation, carpet model), LPS neutralization, biofilm inhibition, immunomodulation (chemotaxis, cytokine modulation), intracellular targeting, synergy with conventional antibiotics.

Key Benefits

  • Broad-spectrum antimicrobial activity
  • Low resistance development
  • Immunomodulatory effects
  • Anti-biofilm properties
  • Wound healing support
  • Synergy with antibiotics
  • Novel infection treatment paradigm

Clinical Applications

Antibiotic-resistant infectionsBiofilm-associated infectionsChronic woundsSepsisImmunodeficiencyFungal and viral infections

Dosing Guidelines

Variable by specific AMP and formulation

Typical DoseHighly variable
FrequencyVariable
DurationCondition-dependent

Topical (most common current use)

Typical DoseFormulation-dependent
Frequency1-3 times daily
DurationUntil infection cleared

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Emerging
Studies

Extensive preclinical research, limited approved therapeutics, clinical trials ongoing

Summary

Robust preclinical evidence across diverse AMPs. Multiple candidates in clinical development. Few approved therapeutics yet (e.g., colistin, polymyxin B for resistant infections). Represents promising frontier in anti-infective therapy with potential to address antibiotic resistance crisis.

Safety Information

Potential Side Effects

  • Variable by specific AMP
  • Potential cytotoxicity (selectivity critical)
  • Local irritation

Contraindications

  • Variable by compound

Interactions

  • May synergize with conventional antibiotics

Quick Facts

CategoryAntimicrobial
SourceNatural host defense peptides (human, animal, plant) or synthetic analogs
Legal StatusMostly research stage; some approved (colistin, polymyxins); topical formulations emerging
Gabriel Brain Score
84/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.